Concepts (258)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alzheimer Disease | 25 | 2022 | 854 | 4.210 |
Why?
|
| Amyloid beta-Peptides | 15 | 2021 | 226 | 3.730 |
Why?
|
| Amyloid beta-Protein Precursor | 19 | 2022 | 133 | 3.230 |
Why?
|
| Mice, Transgenic | 38 | 2024 | 2445 | 2.760 |
Why?
|
| Plaque, Amyloid | 11 | 2021 | 68 | 2.260 |
Why?
|
| Neurons | 14 | 2024 | 1998 | 2.210 |
Why?
|
| Brain | 21 | 2023 | 3183 | 1.860 |
Why?
|
| Entorhinal Cortex | 4 | 2024 | 22 | 1.660 |
Why?
|
| Hippocampus | 10 | 2022 | 816 | 1.630 |
Why?
|
| Dependovirus | 6 | 2021 | 153 | 1.470 |
Why?
|
| Mice | 48 | 2024 | 18507 | 1.330 |
Why?
|
| Amyloid | 6 | 2020 | 69 | 1.280 |
Why?
|
| Tetracycline | 5 | 2024 | 80 | 1.260 |
Why?
|
| Amyloidosis | 3 | 2019 | 74 | 1.220 |
Why?
|
| Disease Models, Animal | 22 | 2024 | 4688 | 1.170 |
Why?
|
| Integrases | 2 | 2022 | 158 | 1.090 |
Why?
|
| Animals | 56 | 2024 | 34882 | 1.080 |
Why?
|
| Spatial Memory | 2 | 2017 | 31 | 1.040 |
Why?
|
| Transduction, Genetic | 4 | 2016 | 293 | 1.010 |
Why?
|
| Transgenes | 8 | 2024 | 335 | 1.000 |
Why?
|
| Spatial Learning | 2 | 2017 | 16 | 0.990 |
Why?
|
| Doxycycline | 4 | 2024 | 120 | 0.940 |
Why?
|
| Cell Death | 3 | 2024 | 241 | 0.920 |
Why?
|
| Membrane Proteins | 6 | 2024 | 1610 | 0.900 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2024 | 38 | 0.890 |
Why?
|
| Mice, Inbred C57BL | 17 | 2024 | 4757 | 0.840 |
Why?
|
| Trans-Activators | 4 | 2024 | 712 | 0.840 |
Why?
|
| Genetic Vectors | 5 | 2021 | 925 | 0.810 |
Why?
|
| Tauopathies | 1 | 2024 | 74 | 0.800 |
Why?
|
| Neural Stem Cells | 1 | 2023 | 149 | 0.750 |
Why?
|
| Nerve Tissue Proteins | 5 | 2024 | 1131 | 0.740 |
Why?
|
| Temporal Lobe | 2 | 2024 | 118 | 0.680 |
Why?
|
| tau Proteins | 3 | 2024 | 235 | 0.670 |
Why?
|
| Genetic Therapy | 3 | 2021 | 719 | 0.620 |
Why?
|
| Protein Kinase C beta | 1 | 2019 | 20 | 0.620 |
Why?
|
| Behavior, Animal | 3 | 2018 | 506 | 0.560 |
Why?
|
| Neurogenesis | 2 | 2023 | 222 | 0.540 |
Why?
|
| Cytokines | 5 | 2001 | 1358 | 0.530 |
Why?
|
| Growth Substances | 4 | 2001 | 109 | 0.520 |
Why?
|
| Neuromuscular Diseases | 1 | 2016 | 50 | 0.490 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2024 | 811 | 0.480 |
Why?
|
| Mutation | 9 | 2024 | 6229 | 0.480 |
Why?
|
| Vesicular Transport Proteins | 1 | 2016 | 122 | 0.480 |
Why?
|
| Immunization, Passive | 2 | 2018 | 128 | 0.470 |
Why?
|
| Microglia | 5 | 2023 | 139 | 0.470 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2018 | 445 | 0.470 |
Why?
|
| Long-Term Potentiation | 3 | 2000 | 110 | 0.460 |
Why?
|
| Kallikreins | 1 | 2015 | 30 | 0.460 |
Why?
|
| Nestin | 1 | 2014 | 18 | 0.430 |
Why?
|
| Gene Transfer Techniques | 2 | 2014 | 346 | 0.430 |
Why?
|
| Spatial Navigation | 1 | 2014 | 23 | 0.430 |
Why?
|
| Presenilin-1 | 7 | 2016 | 57 | 0.410 |
Why?
|
| Adult Stem Cells | 1 | 2014 | 54 | 0.410 |
Why?
|
| Nerve Net | 1 | 2016 | 263 | 0.400 |
Why?
|
| Maze Learning | 5 | 2016 | 104 | 0.400 |
Why?
|
| Cognition | 1 | 2018 | 810 | 0.390 |
Why?
|
| Cell Division | 1 | 2013 | 743 | 0.370 |
Why?
|
| Locomotion | 1 | 2012 | 61 | 0.370 |
Why?
|
| Gene Expression Regulation | 6 | 2019 | 2438 | 0.370 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2012 | 64 | 0.350 |
Why?
|
| Mosaicism | 1 | 2013 | 249 | 0.340 |
Why?
|
| Cerebral Cortex | 1 | 2014 | 480 | 0.340 |
Why?
|
| Environment | 2 | 2014 | 148 | 0.320 |
Why?
|
| Synapses | 3 | 2020 | 456 | 0.320 |
Why?
|
| Male | 22 | 2024 | 64922 | 0.310 |
Why?
|
| Brain Chemistry | 2 | 1999 | 116 | 0.310 |
Why?
|
| Mice, Inbred C3H | 3 | 2016 | 118 | 0.300 |
Why?
|
| Electroencephalography | 1 | 2014 | 908 | 0.300 |
Why?
|
| Seizures | 3 | 2014 | 893 | 0.300 |
Why?
|
| Humans | 33 | 2024 | 132061 | 0.280 |
Why?
|
| Astrocytes | 5 | 2016 | 269 | 0.280 |
Why?
|
| Animals, Newborn | 4 | 2016 | 1035 | 0.270 |
Why?
|
| Mice, Inbred ICR | 2 | 2021 | 151 | 0.270 |
Why?
|
| Neurodegenerative Diseases | 2 | 2017 | 279 | 0.270 |
Why?
|
| Amyloid Precursor Protein Secretases | 3 | 2014 | 58 | 0.260 |
Why?
|
| Signal Transduction | 3 | 2018 | 4703 | 0.260 |
Why?
|
| Cognition Disorders | 2 | 2014 | 568 | 0.250 |
Why?
|
| Cerebral Amyloid Angiopathy | 2 | 2017 | 14 | 0.250 |
Why?
|
| Genes, Reporter | 2 | 2019 | 365 | 0.240 |
Why?
|
| Cell Differentiation | 1 | 2013 | 1960 | 0.240 |
Why?
|
| Female | 18 | 2021 | 70712 | 0.240 |
Why?
|
| Injections, Intraventricular | 2 | 2016 | 60 | 0.230 |
Why?
|
| Analysis of Variance | 4 | 2016 | 1009 | 0.230 |
Why?
|
| Mice, Knockout | 3 | 2024 | 3863 | 0.230 |
Why?
|
| Galactosides | 2 | 2015 | 11 | 0.230 |
Why?
|
| Mental Disorders | 1 | 2012 | 884 | 0.220 |
Why?
|
| Fear | 3 | 2016 | 202 | 0.220 |
Why?
|
| Paralysis | 1 | 2024 | 31 | 0.210 |
Why?
|
| Housing, Animal | 1 | 2003 | 16 | 0.210 |
Why?
|
| Phosphorylation | 2 | 2019 | 1608 | 0.210 |
Why?
|
| Models, Neurological | 2 | 2016 | 208 | 0.210 |
Why?
|
| Solubility | 2 | 2018 | 125 | 0.210 |
Why?
|
| Endopeptidases | 1 | 2003 | 114 | 0.200 |
Why?
|
| Immunohistochemistry | 3 | 2015 | 1694 | 0.200 |
Why?
|
| Respiration | 1 | 2023 | 124 | 0.200 |
Why?
|
| Demyelinating Diseases | 1 | 2023 | 70 | 0.200 |
Why?
|
| Lipopolysaccharides | 1 | 2024 | 306 | 0.190 |
Why?
|
| Nervous System | 1 | 2002 | 126 | 0.180 |
Why?
|
| Complement C3 | 3 | 2020 | 51 | 0.180 |
Why?
|
| Motor Neuron Disease | 2 | 2016 | 18 | 0.180 |
Why?
|
| Interleukin-6 | 2 | 2017 | 433 | 0.160 |
Why?
|
| Interferon-beta | 1 | 2020 | 54 | 0.160 |
Why?
|
| Pilocarpine | 1 | 1999 | 13 | 0.160 |
Why?
|
| NIH 3T3 Cells | 1 | 2019 | 95 | 0.150 |
Why?
|
| Amyotrophic Lateral Sclerosis | 2 | 2016 | 176 | 0.150 |
Why?
|
| Mutation, Missense | 1 | 2003 | 935 | 0.150 |
Why?
|
| Anti-Bacterial Agents | 3 | 2024 | 2558 | 0.150 |
Why?
|
| Software | 1 | 2023 | 732 | 0.150 |
Why?
|
| Inflammation | 2 | 2024 | 1517 | 0.150 |
Why?
|
| Cell Survival | 2 | 2013 | 865 | 0.140 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2009 | 3834 | 0.140 |
Why?
|
| Neurofibrillary Tangles | 1 | 2017 | 25 | 0.140 |
Why?
|
| Status Epilepticus | 1 | 1999 | 158 | 0.140 |
Why?
|
| Protein Kinases | 1 | 2019 | 331 | 0.140 |
Why?
|
| RNA Interference | 1 | 2019 | 514 | 0.130 |
Why?
|
| Alleles | 1 | 2022 | 1686 | 0.130 |
Why?
|
| RNA, Small Interfering | 1 | 2019 | 687 | 0.130 |
Why?
|
| Huntington Disease | 2 | 2012 | 142 | 0.130 |
Why?
|
| Motor Activity | 2 | 2017 | 523 | 0.130 |
Why?
|
| Superoxide Dismutase-1 | 1 | 2016 | 25 | 0.130 |
Why?
|
| Denervation | 1 | 2016 | 30 | 0.130 |
Why?
|
| Brain Mapping | 1 | 2019 | 403 | 0.130 |
Why?
|
| Perforant Pathway | 1 | 2016 | 11 | 0.130 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2011 | 822 | 0.130 |
Why?
|
| Lysosomes | 1 | 2018 | 261 | 0.120 |
Why?
|
| Exploratory Behavior | 2 | 2014 | 55 | 0.120 |
Why?
|
| Motor Neurons | 1 | 2016 | 132 | 0.120 |
Why?
|
| Axon Initial Segment | 1 | 2016 | 24 | 0.120 |
Why?
|
| Gene Knockout Techniques | 1 | 2016 | 136 | 0.120 |
Why?
|
| Complement Activation | 1 | 2016 | 49 | 0.120 |
Why?
|
| Promoter Regions, Genetic | 2 | 2019 | 1280 | 0.120 |
Why?
|
| Protein Structure, Quaternary | 1 | 2015 | 101 | 0.120 |
Why?
|
| Protein Aggregation, Pathological | 1 | 2015 | 28 | 0.120 |
Why?
|
| Spinal Cord | 1 | 2016 | 267 | 0.110 |
Why?
|
| Lac Operon | 1 | 2015 | 92 | 0.110 |
Why?
|
| Axons | 1 | 2018 | 390 | 0.110 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2024 | 2849 | 0.110 |
Why?
|
| Receptors, Complement | 1 | 2014 | 32 | 0.110 |
Why?
|
| Immunity, Innate | 1 | 2017 | 413 | 0.110 |
Why?
|
| Transcription, Genetic | 1 | 1999 | 1422 | 0.110 |
Why?
|
| Drosophila | 1 | 2019 | 823 | 0.110 |
Why?
|
| Drug Therapy, Combination | 1 | 2018 | 1180 | 0.110 |
Why?
|
| Collagen Type IV | 1 | 2014 | 20 | 0.110 |
Why?
|
| Entropy | 1 | 2014 | 29 | 0.110 |
Why?
|
| Suppression, Genetic | 1 | 2014 | 42 | 0.110 |
Why?
|
| Cerebral Arteries | 1 | 2014 | 83 | 0.110 |
Why?
|
| Indoles | 1 | 2015 | 201 | 0.100 |
Why?
|
| Chloride Channels | 1 | 2014 | 63 | 0.100 |
Why?
|
| Luminescent Proteins | 1 | 2014 | 165 | 0.100 |
Why?
|
| Gene Knock-In Techniques | 1 | 2014 | 123 | 0.100 |
Why?
|
| Blood-Brain Barrier | 1 | 2014 | 156 | 0.100 |
Why?
|
| Electrodes, Implanted | 1 | 2014 | 179 | 0.100 |
Why?
|
| Cognitive Dysfunction | 1 | 2017 | 317 | 0.100 |
Why?
|
| Neural Inhibition | 1 | 2014 | 109 | 0.100 |
Why?
|
| Serotyping | 1 | 2013 | 178 | 0.100 |
Why?
|
| Peptides | 3 | 2012 | 847 | 0.100 |
Why?
|
| Capsid | 1 | 2013 | 147 | 0.100 |
Why?
|
| Mice, Inbred CBA | 1 | 2012 | 29 | 0.100 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 1 | 2015 | 309 | 0.090 |
Why?
|
| NF-kappa B | 1 | 2014 | 454 | 0.090 |
Why?
|
| Dentate Gyrus | 1 | 2012 | 39 | 0.090 |
Why?
|
| Genetic Testing | 1 | 2019 | 1098 | 0.090 |
Why?
|
| Cell Lineage | 1 | 2014 | 357 | 0.090 |
Why?
|
| Up-Regulation | 3 | 2020 | 876 | 0.090 |
Why?
|
| Rett Syndrome | 1 | 2015 | 293 | 0.090 |
Why?
|
| Cell Line, Tumor | 1 | 2019 | 3681 | 0.090 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2012 | 144 | 0.090 |
Why?
|
| Species Specificity | 1 | 2012 | 541 | 0.090 |
Why?
|
| RNA, Messenger | 3 | 2004 | 2674 | 0.090 |
Why?
|
| Action Potentials | 1 | 2014 | 494 | 0.090 |
Why?
|
| Animals, Genetically Modified | 1 | 2012 | 338 | 0.090 |
Why?
|
| Receptors, Estrogen | 1 | 2014 | 728 | 0.080 |
Why?
|
| GABA Plasma Membrane Transport Proteins | 1 | 2009 | 9 | 0.080 |
Why?
|
| Chromosome Mapping | 1 | 2012 | 1095 | 0.080 |
Why?
|
| Atrophy | 1 | 2009 | 252 | 0.080 |
Why?
|
| Blotting, Western | 1 | 2011 | 1077 | 0.070 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2009 | 172 | 0.070 |
Why?
|
| Disease Progression | 1 | 2015 | 2224 | 0.070 |
Why?
|
| Biomarkers | 1 | 2018 | 3406 | 0.070 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2009 | 234 | 0.070 |
Why?
|
| Age of Onset | 2 | 2012 | 621 | 0.070 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2000 | 1222 | 0.070 |
Why?
|
| Time Factors | 4 | 2013 | 6448 | 0.060 |
Why?
|
| Proteins | 1 | 2012 | 1036 | 0.060 |
Why?
|
| Cells, Cultured | 3 | 2016 | 3036 | 0.060 |
Why?
|
| Aged, 80 and over | 1 | 2017 | 7102 | 0.060 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2007 | 651 | 0.060 |
Why?
|
| Cellular Senescence | 1 | 2007 | 199 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 1 | 2007 | 764 | 0.060 |
Why?
|
| Aging | 1 | 2012 | 1250 | 0.060 |
Why?
|
| Age Factors | 2 | 2016 | 2912 | 0.060 |
Why?
|
| Chimera | 1 | 2004 | 83 | 0.050 |
Why?
|
| Immunoblotting | 2 | 2001 | 301 | 0.050 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2003 | 32 | 0.050 |
Why?
|
| Plethysmography | 1 | 2023 | 36 | 0.050 |
Why?
|
| Mice, Mutant Strains | 1 | 2004 | 378 | 0.050 |
Why?
|
| Rats | 2 | 2000 | 3611 | 0.050 |
Why?
|
| Amino Acid Sequence | 1 | 2007 | 2669 | 0.050 |
Why?
|
| Prion Diseases | 1 | 2002 | 4 | 0.050 |
Why?
|
| Spinocerebellar Degenerations | 1 | 2002 | 64 | 0.050 |
Why?
|
| Receptors, Immunologic | 1 | 2023 | 126 | 0.050 |
Why?
|
| Trinucleotide Repeats | 1 | 2002 | 108 | 0.050 |
Why?
|
| Molecular Sequence Data | 1 | 2007 | 3770 | 0.050 |
Why?
|
| Pregnancy | 1 | 2014 | 7566 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2004 | 792 | 0.040 |
Why?
|
| Mossy Fibers, Hippocampal | 1 | 2001 | 8 | 0.040 |
Why?
|
| Membrane Glycoproteins | 1 | 2023 | 420 | 0.040 |
Why?
|
| Apolipoproteins E | 1 | 2001 | 200 | 0.040 |
Why?
|
| Nerve Growth Factors | 1 | 2001 | 74 | 0.040 |
Why?
|
| Receptors, Cytokine | 1 | 2000 | 67 | 0.040 |
Why?
|
| Genes | 1 | 2001 | 313 | 0.040 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2001 | 99 | 0.040 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2000 | 118 | 0.040 |
Why?
|
| Oncostatin M | 1 | 1999 | 5 | 0.040 |
Why?
|
| Ciliary Neurotrophic Factor | 1 | 1999 | 10 | 0.040 |
Why?
|
| Leukemia Inhibitory Factor | 1 | 1999 | 27 | 0.040 |
Why?
|
| Growth Inhibitors | 1 | 1999 | 37 | 0.040 |
Why?
|
| Gliosis | 1 | 1999 | 31 | 0.040 |
Why?
|
| Peptide Fragments | 1 | 2003 | 800 | 0.040 |
Why?
|
| Pyramidal Cells | 1 | 2000 | 165 | 0.040 |
Why?
|
| Lymphokines | 1 | 1999 | 66 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2023 | 1491 | 0.040 |
Why?
|
| In Vitro Techniques | 1 | 2000 | 865 | 0.040 |
Why?
|
| Aged | 1 | 2017 | 21406 | 0.040 |
Why?
|
| Regeneration | 1 | 2001 | 226 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2005 | 1882 | 0.040 |
Why?
|
| Reference Values | 1 | 1999 | 708 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2000 | 1284 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2001 | 1548 | 0.030 |
Why?
|
| Middle Aged | 1 | 2017 | 28964 | 0.030 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 1 | 1 | 2016 | 15 | 0.030 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2019 | 386 | 0.030 |
Why?
|
| I-kappa B Proteins | 1 | 2016 | 39 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2023 | 2508 | 0.030 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2016 | 109 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2011 | 13028 | 0.030 |
Why?
|
| Cell Adhesion Molecules | 1 | 2016 | 233 | 0.030 |
Why?
|
| Phagocytosis | 1 | 2016 | 191 | 0.030 |
Why?
|
| Ion Channels | 1 | 2016 | 207 | 0.030 |
Why?
|
| Azepines | 1 | 2014 | 64 | 0.030 |
Why?
|
| Alanine | 1 | 2014 | 159 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2014 | 367 | 0.030 |
Why?
|
| Injections | 1 | 2013 | 153 | 0.020 |
Why?
|
| Viral Tropism | 1 | 2013 | 53 | 0.020 |
Why?
|
| Sensory Gating | 1 | 2012 | 13 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2013 | 396 | 0.020 |
Why?
|
| Huntingtin Protein | 1 | 2012 | 63 | 0.020 |
Why?
|
| Motor Skills | 1 | 2012 | 82 | 0.020 |
Why?
|
| Nanoparticles | 1 | 2014 | 290 | 0.020 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 2012 | 127 | 0.020 |
Why?
|
| Contrast Media | 1 | 2014 | 508 | 0.020 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2009 | 72 | 0.020 |
Why?
|
| Biological Transport | 1 | 2009 | 349 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2009 | 470 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2014 | 2172 | 0.020 |
Why?
|
| Cell Line | 1 | 2009 | 2719 | 0.010 |
Why?
|
| Phenotype | 1 | 2012 | 4529 | 0.010 |
Why?
|
| Apolipoprotein E4 | 1 | 2001 | 47 | 0.010 |
Why?
|